Interestingly, in humans, elevated fetuin-A levels have been associated with metabolic syndrome and its manifestations, namely, obesity, insulin resistance, risk of type 2 diabetes development, and with NAFLD as well as the risk of myocardial infarction and ischemic stroke [199]. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.